2021 Annual Report
Sustainability + Innovation = Growth
2021, record financial performance – strategy executed with agility.
2021 demonstrated once again how our Purpose and Commitment to sustainability are helping to deliver record performance in the face of many challenges.
2021 has been an excellent year for Croda. We delivered a record financial performance, made progress against our sustainability commitments, and progressed our strategic review, refocusing the business on fast growth markets of the future.
The Croda team has met the demands of a rapid global recovery, combined with ongoing challenges presented by COVID-19. Customer demand and cost inflation have been at levels we have not seen for a decade; at the same time COVID-19 restrictions have remained in place in many countries around the world. This has presented many challenges for our people, carefully managing both employee wellbeing and customer expectations.
As always, our clarity of Purpose has been our guide, ensuring we deliver for our customers, whilst always looking after our business partners and one another. Our success is made possible by our people, who have risen to the challenges the year has presented. Their hard work, dedication and customer focus have been exceptional.
Download the Chair's statement here
2021 has been an outstanding year for Croda, with record financial results and excellent strategic progress. This has been enabled through the accelerated implementation of our strategic priorities, increased investment in innovation and growth, and a broader global recovery in demand. Our excellent strategic progress during the COVID-19 pandemic has included progressing our transition to a pure-play Consumer Care and Life Sciences company.
Download the CEO statement here
Sales performance was excellent across all sectors, augmented by raw material cost recovery. We expect to continue with the current accelerated capital reinvestment and acquisition programmes over the next three years, given the strong demand environment and range of growth and technology opportunities in Consumer Care and Life Sciences.
Download the CFO statement here
Our focus on growth, innovation and sustainability aims to ensure that Croda smart science helps our customers everywhere to deliver on their consumer and sustainability commitments, while we continue creating sustainable value as a business.
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccinesRead more
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.Read more